Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Texas Health Dallas offers heart and vascular screening program for women

When Mary Gill went to bed that night, nothing would have made anyone think heart disease — not even Mary. She was thin and 42 years old. She exercised regularly, ate a healthy diet and never smoked.

4 Feb 2010

Ontario's doctors urge patients to make simple lifestyle changes for better health

The number of patients living with chronic disease in Ontario is on the rise, finds a new report by the Ontario Medical Association (OMA). The study reveals that between 1995-2005, the number of patients with diabetes has increased over 50% and more concerning is that the number of patients with diabetes aged 19 and younger has gone up by 20%.

4 Feb 2010

New technique may reduce recovery time in arrhythmia patients

A surgeon and an electrophysiologist in the Methodist DeBakey Heart & Vascular Center last week worked together to perform a novel, minimally-invasive procedure to treat a common but dangerous arrhythmia in a 61-year-old lawyer from east Texas who has suffered from the condition for months.

4 Feb 2010

Geisinger Health System and TGen sign research agreement

Geisinger Health System and the Translational Genomics Research Institute today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

St. Jude Medical to commence enrollment in IRASE AF trial

St. Jude Medical, Inc. today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the IRASE AF (IRrigated Ablation System Evaluation for AF) trial, a multicenter, randomized, single-blind study evaluating the safety and efficacy of the company’s Duo 12 port open irrigated catheter ablation system for treatment of Atrial Fibrillation (AF). AF is the most common cardiac arrhythmia (abnormal heartbeat), affecting an estimated 3.3 million Americans and millions more worldwide.

4 Feb 2010

TGen, Geisinger Health System sign strategic research agreement

The Translational Genomics Research Institute (TGen) and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

Tough economy adds stress to hospitals; Community health centers help fill gaps

Hospitals get mixed marks while many suffer from the effects of the struggling economy. Meanwhile, community health centers increasingly provide more care and help fill in health care gaps.

4 Feb 2010

Innovative discharge program reduces congestive heart failure readmissions

An innovative discharge program developed by Saddleback Memorial Medical Center combining coordination of hospital and community resources, strong patient education and the IDEAL LIFE Bluetooth-enabled wireless remote health monitoring system has helped to reduce congestive heart failure (CHF) readmissions by 50 percent

3 Feb 2010

Apple Valley Medical Center to hold free Heart Failure Community Education Evening

A free Heart Failure Community Education Evening will be held from 6:00 p.m. to 8:00 p.m. on Tuesday, February 9, 2010, at the Apple Valley Medical Center.

3 Feb 2010

Decreased release of neurotransmitter acetylcholine contributes to heart failure

Scientists at the Robarts Research Institute at The University of Western Ontario, working in collaboration with researchers in Brazil, have used a unique genetically-modified mouse line to reveal a previously unidentified mechanism contributing to heart failure.

2 Feb 2010

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Cardiac catheterizations have been a groundbreaking tool in the field of cardiology. This procedure offers a minimally invasive means for obtaining important information about the heart and its blood vessels, while also providing a less invasive treatment for certain heart conditions.

2 Feb 2010

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

Response Biomedical Corporation announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company’s diagnostic products, expanding its strategic presence in this important global market.

2 Feb 2010

FDA approves neurostimulation treatment for heart failure

The FDA recently approved the first study of neurostimulation as a treatment for heart failure, a chronic disease that affects nearly six million Americans and is the leading cause of hospitalization in America.

2 Feb 2010

Lebanon Cardiology Associates and The Good Samaritan Hospital team up to implement hypothermia protocol for improved cardiac care

Lebanon Cardiology Associates teamed with The Good Samaritan Hospital to implement one of the top 15% performing emergency cardiac catheterization teams treating heart attacks in the United States.

29 Jan 2010

Thoratec reports revenues of $373.9M for fiscal 2009

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that a 30 percent growth in revenues from its Cardiovascular Division in fiscal 2009 led to a 19 percent increase in total 2009 revenues versus those in fiscal 2008.

29 Jan 2010

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.

28 Jan 2010

Leukemia cells rely on fatty acid metabolism to grow and evade cell death

Leukemia cells, like most cancers, are addicted to glucose to generate their energy, but new research shows for the first time that these cells also rely on fatty acid metabolism to grow and to evade cell death.

28 Jan 2010

Study shows benefits of endoscopic sinus surgery for patients with chronic sinusitis

Adults with chronic rhinosinusitis -a debilitating inflammation of the nasal passages that lasts for months and keeps coming back - report significantly improved quality of life following minimally invasive endoscopic sinus surgery, according to a new study led by Oregon Health & Science University (OHSU).

28 Jan 2010

Abiomed integrates Opsens’ sensor technology into its Impella catheter

Abiomed, Inc., a leading provider of breakthrough heart support technologies designed for heart recovery, today announced a strategic partnership with Opsens, a leading developer of fiber optic sensors. Through this partnership, Opsens’ breakthrough sensor technology will be integrated into the Impella® catheter to provide robust blood pressure measurements that can be used to enhance Impella’s performance and ease-of-use.

28 Jan 2010

BG Medicine launches new, CE-marked galectin-3 test

BG Medicine, Inc., a privately-held developer of biomarker-based in vitro diagnostics, today announced the commercial launch in the European Union of a new, CE-marked test for the measurement of galectin-3 in human plasma or serum. Galectin-3 was first shown by researchers at the University of Maastricht, The Netherlands, to play an integral role in the development and progression of heart failure.

27 Jan 2010